We use a session cookie and first-party analytics to run this site — no third-party trackers, no ads. Details in our Privacy Policy.
RESEARCH From the Research Desk — The sub-Rs 100 crore acquisition market, sized. Read it →
Home/ Cases/ Pharmaceuticals/ S.m. Pharmaceuticals Private Limited
● UNDER CIRP

S.m. Pharmaceuticals Private Limited

Corporate insolvency resolution — proceedings ongoing · source: Live - IBBI EoI

Metals & chemicals manufacturer · private limited company · incorporated 2018 · 6 years old at admission

Sector Pharmaceuticals Bench NCLT Bengaluru CIN U24230KA2018PTC119625 Admitted 16 Jun 2025 Initiated by State Bank of India Last process activity 15 Nov 2025 · claims re-verified

Claims — past the ninety-day period. The public announcement set 4 Jul 2025, and the ninety days from admission that regulation 12 allows ended 14 Sep 2025. A claim filed now must state its reasons for the delay, and it is for Nethi Mallikarjuna Setty to accept or reject it. How claims are filed →

Case record

the public record -- figures open below

Corporate insolvency record of S.m. Pharmaceuticals Private Limited, commenced 16 Jun 2025, at NCLT Bengaluru, initiated by State Bank of India. Current status: Under CIRP. A Form G invitation for expression of interest is on record; the round closes 01 Nov 2025.

CIN
U24230KA2018PTC119625
Incorporated
2018
Registered State
Karnataka
NCLT Bench
Bengaluru
Initiated by
State Bank of India
Public Announcement
22 Jun 2025
EoI Last Date
01 Nov 2025
PRA List Date
11 Nov 2025
Objections By
16 Nov 2025
Commencement
16 Jun 2025
Sector
Pharmaceuticals
Resolution Professional
Nethi Mallikarjuna Setty →
Subscriber access

Full case intelligence is gated

This page's financial detail is available to stressed.in subscribers — for ARCs, PE funds and resolution professionals.

Admitted claims Recovery waterfall & haircut Sector benchmarks Case timeline & professionals Committee of creditors Plan value & CoC vote Intelligence note
See plans →
Just this company — Rs 1,999 · apply for access →

One company, bought outright — yours permanently, including future updates. Subscribe within 30 days and the whole Rs 1,999 comes off your first month, so starting with one case costs nothing against subscribing later.

Questions? WhatsApp us →
Other Pharmaceuticals cases
Kudos Chemie Limited
Resolved
Parabolic Drugs Limited
Resolved
Kandla Energy and Chemicals Limited
Liquidation
Apex Drugs Ltd.
Resolved
Sources, basis and disclaimers → ·
report an error